Neurocutaneous Melanocytosis Registry

ConditionsCutaneous Melanocytic Neoplasm Large Cutaneous Melanocytic Nevi Neurocutaneous Melanocytosis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorMemorial Sloan Kettering Cancer Center

About this trial

This study will involve collecting information about the regular medical care you receive for large cutaneous melanocytic nevi (LCMN) or neurocutaneous melanocytosis (NCM).

Eligibility criteria

Qualifiers

Dark-colored patch of skin present at birth

Can be located anywhere on the individual's skin

May include satellite lesions

May be associated with hypertrichosis

Disqualifiers

Informed consent has not been provided.

Trial design

Treatments tested in this trial

Not listed

Trial groups

100 Participants

are grouped into 1 trial group

Locations

Boston Children's Hospital (Data Analysis Only)02115, BostonMassachusetts, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)10065, New YorkNew York, United States

Sponsors and collaborators

Memorial Sloan Kettering Cancer Center

Lead sponsor

Source ClinicalTrials.gov